News | August 22, 2013

Real-time Assessment of Tumor Response Presentation Wins Innovation Competition

Award goes to Dr. Kai Chen at the 2013 SNMMI meeting

August 22, 2013 — Molecular Targeting Technologies Inc. (MTTI) announced Dr. Kai Chen of the University of Southern California was awarded the 2013 Center for Molecular Imaging Innovation and Translation (CMIIT) Young Investigator Award during the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver, Canada. Chen presented results from his study entitled: “Synthesis and evaluation of a novel bis (zinc(II)-dipicolyamine) derivative for dual-modality PET/NIRF (positron emission tomography/near-infrared flourescence) imaging of phosphatidylserine exposure.”

This real-time assessment probe can be used to monitor tumor response in as early as one day to evaluate treatment efficacy and intervene early in treatment modification. Non-invasive imaging of drug response has a significant clinical impact and can be broadly useful for monitoring numerous conditions, including cancer, cardiovascular diseases, neurology and renal diseases.

Chen, assistant professor of the department of radiology at USC said, “Novel tools to assist in the non-invasive, real-time assessment of tumor response to anti-cancer treatment are urgently needed. Our current preclinical results could lead to a robust imaging agent, offering synergistic advantages, not only to allow comprehensive collection of cell death information, but also to facilitate clinical applications of image-guided surgery.”

For more information: mic.usc.edu, www.mtarget.com

Related Content

News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Overlay Init